These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 9719125)

  • 1. Radiobiologically based assessments of the net costs of fractionated focal radiotherapy.
    Jones B; Dale RG
    Int J Radiat Oncol Biol Phys; 1998 Jul; 41(5):1139-48. PubMed ID: 9719125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Derivation of the optimum dose per fraction from the linear quadratic model.
    Jones B; Tan LT; Dale RG
    Br J Radiol; 1995 Aug; 68(812):894-902. PubMed ID: 7551788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiobiologically based assessments of the net costs of fractionated radiotherapy.
    Dale RG; Jones B
    Int J Radiat Oncol Biol Phys; 1996 Oct; 36(3):739-46. PubMed ID: 8948360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inclusion of molecular biotherapies with radical radiotherapy: modeling of combined modality treatment schedules.
    Jones B; Dale RG
    Int J Radiat Oncol Biol Phys; 1999 Nov; 45(4):1025-34. PubMed ID: 10571212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiobiological modeling and clinical trials.
    Jones B; Dale RG
    Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):259-65. PubMed ID: 10924997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Limitations of a convolution method for modeling geometric uncertainties in radiation therapy: the radiobiological dose-per-fraction effect.
    Song W; Battista J; Van Dyk J
    Med Phys; 2004 Nov; 31(11):3034-45. PubMed ID: 15587657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coupling I-125 permanent implant prostate brachytherapy Monte Carlo dose calculations with radiobiological models.
    Miksys N; Haidari M; Vigneault E; Martin AG; Beaulieu L; Thomson RM
    Med Phys; 2017 Aug; 44(8):4329-4340. PubMed ID: 28455849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The optimal fraction size in high-dose-rate brachytherapy: dependency on tissue repair kinetics and low-dose rate.
    Sminia P; Schneider CJ; Fowler JF
    Int J Radiat Oncol Biol Phys; 2002 Mar; 52(3):844-9. PubMed ID: 11849810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repopulation of interacting tumor cells during fractionated radiotherapy: stochastic modeling of the tumor control probability.
    Fakir H; Hlatky L; Li H; Sachs R
    Med Phys; 2013 Dec; 40(12):121716. PubMed ID: 24320502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of radiation therapy optimization.
    Brahme A
    Acta Oncol; 2000; 39(5):579-95. PubMed ID: 11093366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mathematical models of tumour and normal tissue response.
    Jones B; Dale RG
    Acta Oncol; 1999; 38(7):883-93. PubMed ID: 10606418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estimation of optimum dose per fraction for high LET radiations: implications for proton radiotherapy.
    Jones B; Dale RG
    Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1549-57. PubMed ID: 11121661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Theoretical effectiveness of cell survival in fractionated radiotherapy with hypoxia-targeted dose escalation.
    Chvetsov AV; Rajendran JG; Zeng J; Patel SA; Bowen SR; Kim EY
    Med Phys; 2017 May; 44(5):1975-1982. PubMed ID: 28236652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A TCP-NTCP estimation module using DVHs and known radiobiological models and parameter sets.
    Warkentin B; Stavrev P; Stavreva N; Field C; Fallone BG
    J Appl Clin Med Phys; 2004; 5(1):50-63. PubMed ID: 15753933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling the effect of intratumoral heterogeneity of radiosensitivity on tumor response over the course of fractionated radiation therapy.
    Alfonso JCL; Berk L
    Radiat Oncol; 2019 May; 14(1):88. PubMed ID: 31146751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of prolonged fraction delivery times on tumor control: a note of caution for intensity-modulated radiation therapy (IMRT).
    Wang JZ; Li XA; D'Souza WD; Stewart RD
    Int J Radiat Oncol Biol Phys; 2003 Oct; 57(2):543-52. PubMed ID: 12957268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
    Lunsford LD; Flickinger JC; Larson D
    Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of tumor repopulation on radiotherapy planning.
    Wang JZ; Li XA
    Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):220-7. PubMed ID: 15629615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dosimetry and radiobiologic model comparison of IMRT and 3D conformal radiotherapy in treatment of carcinoma of the prostate.
    Luxton G; Hancock SL; Boyer AL
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):267-84. PubMed ID: 15093924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A radiobiological model of reoxygenation and fractionation effects.
    Guerrero M; Carlson DJ
    Med Phys; 2017 May; 44(5):2002-2010. PubMed ID: 28273349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.